Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right track.
| Ticker |
Sentiment |
Impact |
|
MDGL
|
Somewhat Bullish
|
5 %
|
|
VKTX
|
Neutral
|
43 %
|
|
MS
|
Neutral
|
5 %
|
